AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

673.808

-2.556-0.38%

Number of Gainers:10

Number of Losers:14

Number of Flat:19

PE:- -

High:685.239

Open:680.163

Low:669.907

Close:676.364

Volume:63.38M

Turnover:92.19M

Market Cap:96.84B

Float Cap:93.72B

Loading ...

Mayne Pharma Group - Settlement Made Without Admission of Liability or Wrongdoing by Mayne Pharma

THOMSON REUTERS

Mayne Pharma Group - Announces Agreement to Resolve Civil Complaint from 49 US States

THOMSON REUTERS

ASX Growth Stocks To Watch With Up To 28% Insider Ownership

Simply Wall St.

Elite Australian Growth Stocks To Own In September 2026

Simply Wall St.

NASDAQ Trade Halt Halt News Pending at 07:50 Pm

Paradigm Biopharmaceuticals to Return $2 Million of Funds to Obsidian Global

MT Newswires Live

Paradigm Biopharmaceuticals Ltd-Agreement to Return US$2M to Obsidian

THOMSON REUTERS

Paradigm Biopharmaceuticals - 2 Mln Convertible Notes Issued in Tranche 4 Drawdown to be Cancelled

THOMSON REUTERS

Australia's Mesoblast Rises on FDA Approval for New Potency Assay for Commercial Ryoncil

Mesoblast - Receives FDA Approval for New Potency Assay for Commercial Ryoncil Product

THOMSON REUTERS

3 ASX Growth Companies With Up To 15% Insider Ownership

Simply Wall St.

Hexcel Poised to Continue to Benefit From its Widebody Aircraft Exposure, RBC Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK7508/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":673.8078,"timestamp":1791435599598,"preClose":676.3637,"halted":0,"volume":63375929,"delay":0,"changeRate":-0.003779,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-2.555908,"latestTime":"10-08 16:00:00 AEDT","open":680.1626,"high":685.2389,"low":669.9068,"amount":92191055,"amplitude":0.022668,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791500400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791414000000,1791435600000]],"turnoverRate":0.00252,"increases":9,"decrements":13,"flats":20,"marketCap":96835706888,"floatMarketCap":93723403428.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":685.2389,"amplitude":0.022668,"preClose":676.3637,"low":669.9068,"latestPrice":673.8078,"volume":63375929,"delay":0,"open":680.1626,"prevYearClose":644.3692,"prevWeekClose":654.21,"prevMonthClose":689.549,"prevQuarterClose":689.549,"fiveDayClose":666.631,"twentyDayClose":646.103,"sixtyDayClose":495.646,"secType":"PLATE","market":"AU","turnoverRate":0.00252,"marketCap":96835706888,"floatMarketCap":93723403428.875,"timestamp":1791435599598,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":10,"down":14,"flat":19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670747404","title":"Mayne Pharma Group - Settlement Made Without Admission of Liability or Wrongdoing by Mayne Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2670747404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670747404?lang=en_us&edition=fundamental","pubTime":"2026-09-28 07:45","pubTimestamp":1790552739,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260927:nFWN45I00I:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670404742","title":"Mayne Pharma Group - Announces Agreement to Resolve Civil Complaint from 49 US States","url":"https://stock-news.laohu8.com/highlight/detail?id=2670404742","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670404742?lang=en_us&edition=fundamental","pubTime":"2026-09-28 07:45","pubTimestamp":1790552739,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260927:nFWN45I00I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","MYX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670392032","title":"ASX Growth Stocks To Watch With Up To 28% Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2670392032","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670392032?lang=en_us&edition=fundamental","pubTime":"2026-09-28 03:07","pubTimestamp":1790536078,"startTime":"0","endTime":"0","summary":"In the current Australian market landscape, a weaker overnight session in the US has cast a shadow over technology and growth-sensitive sectors on the ASX, though potential stability in miners and energy stocks could offer some relief. Amid these fluctuations, identifying growth companies with significant insider ownership can be appealing as it often signals confidence from those closest to the business.","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3041000-choice1-card/1788945089957","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3041000-choice1-card/1788945089957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/capital-goods/asx-dur/duratec-shares/news/asx-growth-stocks-to-watch-with-up-to-28-insider-ownership","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/capital-goods/asx-dur/duratec-shares/news/asx-growth-stocks-to-watch-with-up-to-28-insider-ownership","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SLF.AU","AR1.AU","ELS.AU","VAS.AU","BK7104","E200.AU","BK7023","BK7093","QRE.AU","XKO.AU","AV1.AU","AEM.AU","P1E.AU","WZR.AU","BBOZ.AU","BK7005","BK7110","CDIG","FRS.AU","IMLC.AU","OZR.AU","BK7501","XAO.AU","XJO.AU","OZF.AU","VAP.AU","IOZ.AU","BK7084","BK7062","IISV.AU","PDI.AU","SPL.AU","EIGA.AU","DACE.AU","BK7017","QFN.AU","DUR.AU","BTL.AU","BK7095","BEAR.AU","GEAR.AU","SKS.AU","IIGF.AU","ZYAU.AU","STW.AU","GIVE.AU","BK7508","BK7096","BK7016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670707554","title":"Elite Australian Growth Stocks To Own In September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670707554","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670707554?lang=en_us&edition=fundamental","pubTime":"2026-09-26 11:28","pubTimestamp":1790393289,"startTime":"0","endTime":"0","summary":"Rising long term bond yields have pushed borrowing costs higher, which puts pressure on many growth stocks that rely heavily on cheap debt. That makes financially healthier Australian growth stories more interesting right now. This screener focuses on businesses where analysts see strong earnings growth potential and balance sheets that can better handle higher rates. In this article, you will see three of the strongest candidates from that group.\nThe three Australian stocks highlighted below...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice1-card/1788960340613","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice1-card/1788960340613"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/elite-australian-growth-stocks-to-own-in-september-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/elite-australian-growth-stocks-to-own-in-september-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QTOC","GEAR.AU","4DX.AU","VAS.AU","BBOZ.AU","QFN.AU","STW.AU","XJO.AU","BK7508","AIPO","VAP.AU","XAO.AU","XKO.AU","MP1.AU","BK7096","GIVE.AU","BEAR.AU","EIGA.AU","IMLC.AU","SLF.AU","VTHR","E200.AU","OZR.AU","ARTY","AGIX","BK7043","IIGF.AU","BK7094","NEU.AU","IOZ.AU","OZF.AU","QRE.AU","ZYAU.AU","CHAT","IISV.AU","DACE.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670208384","title":"NASDAQ Trade Halt Halt News Pending at 07:50 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2670208384","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670208384?lang=en_us&edition=fundamental","pubTime":"2026-09-26 07:50","pubTimestamp":1790380200,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 07:50 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nAQN2MKW2S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMMP","BK7508","BK7067","IMM.AU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669541554","title":"Paradigm Biopharmaceuticals to Return $2 Million of Funds to Obsidian Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2669541554","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669541554?lang=en_us&edition=fundamental","pubTime":"2026-09-24 14:12","pubTimestamp":1790230359,"startTime":"0","endTime":"0","summary":"Paradigm Biopharmaceuticals  agreed to return the $2 million of funds it recently received from Obsidian Global under a fourth-tranche drawdown of its convertible note facility, according to a Thursday filing with the Australian bourse.The 2 million convertible notes issued in connection with the drawdown will be cancelled, and no premium, redemption amount, or other amount is payable by Paradigm under the arrangement, per the filing.The development follows the interim efficacy result for Paradigm's phase 3 trial of injectable pentosan polysulfate sodium for the treatment of knee osteoarthritis failing to reach the threshold required for the study to proceed.The company is reviewing data to better understand what impact that trial result will have on its financial position and future operations.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PAR.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669451310","title":"Paradigm Biopharmaceuticals Ltd-Agreement to Return US$2M to Obsidian","url":"https://stock-news.laohu8.com/highlight/detail?id=2669451310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669451310?lang=en_us&edition=fundamental","pubTime":"2026-09-24 13:25","pubTimestamp":1790227524,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUE2K4JSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PAR.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669341451","title":"Paradigm Biopharmaceuticals - 2 Mln Convertible Notes Issued in Tranche 4 Drawdown to be Cancelled","url":"https://stock-news.laohu8.com/highlight/detail?id=2669341451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669341451?lang=en_us&edition=fundamental","pubTime":"2026-09-24 13:25","pubTimestamp":1790227524,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUE2K4JSC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PAR.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669379574","title":"Australia's Mesoblast Rises on FDA Approval for New Potency Assay for Commercial Ryoncil","url":"https://stock-news.laohu8.com/highlight/detail?id=2669379574","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669379574?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:38","pubTimestamp":1790210283,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mesoblast rises on FDA approval for new potency assay for commercial Ryoncil** Shares of MesoblastMSB.AXrise as much as 5.1% to A$2.29, their biggest intraday pct gain since August 28","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G01P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","MSB.AU","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669432383","title":"Mesoblast - Receives FDA Approval for New Potency Assay for Commercial Ryoncil Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2669432383","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669432383?lang=en_us&edition=fundamental","pubTime":"2026-09-24 07:52","pubTimestamp":1790207540,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUEBVRFV4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK4139","BK7067","MESO","MSB.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669459671","title":"3 ASX Growth Companies With Up To 15% Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2669459671","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669459671?lang=en_us&edition=fundamental","pubTime":"2026-09-24 03:08","pubTimestamp":1790190481,"startTime":"0","endTime":"0","summary":"As the Australian market opens with a modestly positive outlook, influenced by Wall Street's tech-driven gains and ongoing discussions around interest rates, investors are keenly watching how local technology stocks respond amidst broader economic uncertainties. In this environment, growth companies with high insider ownership can offer unique insights into potential long-term value creation, as insiders typically have a vested interest in the company's success and may provide stability amid...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/7131000-choice1-card/1788935066370","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/7131000-choice1-card/1788935066370"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/diversified-financials/asx-mfg/magellan-financial-group-shares/news/3-asx-growth-companies-with-up-to-15-insider-ownership","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/diversified-financials/asx-mfg/magellan-financial-group-shares/news/3-asx-growth-companies-with-up-to-15-insider-ownership","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XKO.AU","AV1.AU","IMLC.AU","CBO.AU","QFN.AU","WZR.AU","E200.AU","DXN.AU","AEM.AU","VAS.AU","XAO.AU","FRS.AU","SPL.AU","BBOZ.AU","BK7016","BK7142","GEAR.AU","P1E.AU","BK7501","BK7095","BK7508","AR1.AU","BK7096","EIGA.AU","STW.AU","AYA.AU","BK7023","DACE.AU","BEAR.AU","SKS.AU","QRE.AU","BK7017","BK7104","IIGF.AU","IOZ.AU","MFG.AU","PDI.AU","GIVE.AU","ZYAU.AU","BK7043","OZF.AU","SLF.AU","BK7094","XJO.AU","OZR.AU","BK7062","IISV.AU","BK7110","VAP.AU","BK7141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669091482","title":"Hexcel Poised to Continue to Benefit From its Widebody Aircraft Exposure, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669091482","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669091482?lang=en_us&edition=fundamental","pubTime":"2026-09-23 23:29","pubTimestamp":1790177377,"startTime":"0","endTime":"0","summary":"Hexcel (HXL) is poised to continue to benefit from its widebody aircraft exposure, as current widebody fleet dynamics support a strong aftermarket outlook, RBC Capital Markets said in a Tuesday note.R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BZZ","MISL","LU0205194284.USD","BOED","LU0240878834.USD","BK4564","IDEF","LU0072461881.USD","BK7508","LU0240877869.USD","BK4516","BK7067","ROKT","HXL","BK4585","BK4551","LU2326559502.SGD","PPA","BOEU","LU1435385759.SGD","HXL.AU","LU0053671581.USD","BK4588","LU1429558221.USD","NATO","LU0162691827.USD","BK4187","BA","BOEG","LU0205193047.USD","ITA","FOWF","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":92,"code":"91000000","status":"200"}]}}